JACKSONVILLE, Fla.--(BUSINESS WIRE)--Healogics will be featured among national medical leaders, academic experts, scientists and the U.S. Department of Defense at The Ohio State University this week to share the latest innovations in regenerative medicine.
The 2017 Translational to Clinical (T2C) Regenerative Medicine Wound Care Conference hosted by The Ohio State University Wexner Medical Center’s Comprehensive Wound Center and Center for Regenerative Medicine and Cell-Based Therapies is being held March 9-11, 2017, at the Ohio Union on the campus of Ohio State.
This year’s 10th annual conference focuses on the management, treatment and prevention of chronic wounds which affects more than 6.5 million patients yearly in the U.S., and costs more than $25 billion annually. The Conference will feature presentations by national experts, including Healogics President & CEO Jeff Nelson.
Healogics is being recognized as the flagship partner of Ohio State University’s Comprehensive Center for Wound Care. Healogics Chief Medical Officer, Scott Covington, MD; Chief Science Officer, Bill Ennis, DO; and Chief Nursing Officer, Deborah Leblanc, RN, will present on national best practices and advancements in wound care.
About Healogics, Inc.
Headquartered in Jacksonville, Fla., Healogics is the nation’s largest provider of advanced wound care services. Healogics and its affiliated companies manage nearly 800 Wound Care Centers® in the nation and saw over 300,000 new patients in 2016 through a connected network of partner hospitals and Wound Care Centers, academic medical centers, and other post‐acute sites. Healogics employs an evidence‐based, systematic approach to chronic wound healing to treat an underserved and growing patient population. For more information, please visit www.healogics.com.